| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |